1 Incredible Reason to Buy Nvidia Stock Before Feb. 25

Nvidia will report fourth-quarter and full FY2026 results on Feb. 25 (FY ends Jan. 31); the company has delivered 11 consecutive quarters of revenue growth, with Q3 revenue a record $57 billion (+62% YoY) and Q4 revenue consensus at about $65 billion implying roughly $213 billion in FY sales. Nvidia also cites a roughly $500 billion order backlog through end-2026 and won U.S. authorization to sell H200 chips in China, supporting continued AI-driven GPU demand, though shares trade at elevated multiples (~47x trailing, ~41x forward). These metrics suggest the upcoming report is likely to be viewed positively by investors and could materially influence NVDA positioning.

Analysis

Market structure: Nvidia (NVDA) is the primary beneficiary — hyperscalers (MSFT, GOOGL, AMZN), cloud GPU resellers, and equipment suppliers (TSM/ASML) pick up incremental pricing power as a $500bn order backlog through 2026 implies demand well above current supply capacity. Incumbent rivals (AMD, Intel) and smaller GPU makers face share-pressure and ASP compression unless they materially close the performance gap; customers with limited budgets will be incremental losers as capacity scarcity keeps prices elevated.

Risk assessment: Immediate (days) — Feb 25, 2026 earnings are a likely positive catalyst; expect event-driven IV and directionally higher price action but risk of >10% mean reversion post-print. Short-to-medium (weeks–months) risks include export-control reversal, TSMC capacity shocks, or a 5–10% macro slowdown cutting AI capex. Long-term (years) durability depends on software lock-in (CUDA), share of data-center spend, and the convertibility of the $500bn backlog into booked, non-cancellable revenue.

Trade implications: Position NVDA as an idiosyncratic growth play with disciplined sizing and hedges — consider options to cap downside and use relative trades (long NVDA / short AMD or SOXX) to isolate AI-driven share gains. Upstream beneficiaries (TSM/ASML) are tactical longs for 12–24 months to capture capex tailwinds; avoid broad cyclical silicon exposure without AI linkage.

Contrarian angles: Consensus underestimates backlog cancellability and concentration risk — the $500bn figure could include loosely committed orders or prepayments; valuation (41x forward) prices near-perfect execution. Watch for in‑house hyperscaler silicon programs and potential antitrust/supply-chain scrutiny if NVDA becomes too dominant; a >5% revenue guide miss or backlog revision should be treated as a sell signal.

Key Decisions for Investors

• Establish a 2% portfolio long in NVDA ahead of Feb 25 earnings (size to 1% if already overweight); simultaneously buy 1% notional of 3–4 week protective puts ~7–10% OTM to cap downside around the event. If NVDA beats revenue by >3% and raises FY27 guide, add 1% within 48 hours.
• Implement a dollar‑neutral pair: long NVDA (1% portfolio) / short AMD (1% portfolio) or short SOXX (0.8%) to express NVDA-specific AI share gains while hedging semiconductor cyclicality; close or rebalance if the spread narrows by 10% or after 6 months.
• Initiate 1.5% positions in TSM (TSM) and/or ASML (ASML) split 60/40 for 12–24 months to capture wafer‑capacity and lithography capex tailwinds; sell down if TSMC monthly wafer shipments growth falls below +5% YoY or utilization <90%.
• Reduce non‑AI semiconductor ETF exposure (e.g., trim SOXX/SMH holdings by 20–30%) and redeploy proceeds into NVDA/AI software (MSFT, GOOGL) where revenue is directly tied to GPU adoption; reassess if NVDA guidance misses by >5% or implied vol for near-term options falls below historical 60%.